NCT00153660View on ClinicalTrials.gov

Celecoxib Versus Naproxen for Prevention of Recurrent Ulcer Bleeding in Arthritis Patients

PHASE3CompletedINTERVENTIONAL
Enrollment

514

Participants

Timeline

Start Date

June 30, 2005

Primary Completion Date

November 30, 2014

Study Completion Date

December 31, 2016

Conditions
ArthritisCardiovascular DiseasesCerebrovascular Disorders
Interventions
DRUG

Celecoxib(drug)

Celecoxib 100 mg bd

DRUG

Naproxen(drug)

Naproxen 500 mg bd

Trial Locations (1)

Unknown

Endoscopy Center, Prince of Wales Hospital, Shatin

All Listed Sponsors
lead

Chinese University of Hong Kong

OTHER

NCT00153660 - Celecoxib Versus Naproxen for Prevention of Recurrent Ulcer Bleeding in Arthritis Patients | Biotech Hunter | Biotech Hunter